AMERICAN JOINT COMMITTEE ON CANCER

美国癌症联合委员会

• 批准号: 3163495
• 负责人: OLIVER H BEAHRS
• 金额: $ 5.44万
• 依托单位: AMERICAN COLLEGE OF SURGEONS
• 依托单位国家: 美国
• 财政年份: 1980
• 资助国家: 美国
• 起止时间: 1980-03-01 至 1990-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3163495
• 关键词: Hodgkin's disease; bladder neoplasm; bone neoplasms; brain neoplasms; breast neoplasms; cancer information system; cancer registry /resource; data collection; female reproductive system neoplasm; information dissemination; information retrieval; medical records; neoplasm /cancer classification /staging; neoplasm /cancer diagnosis; neoplasm /cancer epidemiology; nose neoplasm; ovary neoplasms; pancreatic islet neoplasm; prognosis; prostate neoplasms; rectum neoplasms; salivary gland neoplasms; statistics /biometry; testis neoplasms; thyroid neoplasm; urinary tract neoplasms; vagina

The American Joint Committee has been engaged in a clinical research project to develop staging classifications for cancer of all anatomic sites. During the past year following considerable thought as to the future activities of the AJC, the following plan has resulted: 1) To complete classifications where further work is needed: bone, central nervous system, melanoma, and GU malignancies; (2) To encourage the use of classification for staging in end results reporting, reporting to journals, libraries, cancer registries, and medical societies; 3) To work with groups on a national level who are doing cancer staging, i.e., SEER, CCPDS, CICA, ACCC, ACOS, and other central and hospital registries, to develop a common computer code; (4) To further refine, publicize, distribute and encourage use of specific site cancer data collection forms; 5) To test the validity of the classifications, with data from SEER and other groups; 6) To evaluate biological markers and other factors which are important in classification of specific cancers and their prognoses, and to determine their relative importance; 7) To evaluate the relative importance and cost effectiveness of various tests and procedures utilized in pretreatment clinical staging and in posttreatment follow-up evaluations, in an effort to discourage over-utilization of expensive tests which are rarely positive and add little to management.

美国联合委员会一直在进行一项临床研究项目